If you saw a medically inoperable patient for chemoRT for muscle-invasive bladder cancer who had a congenital recto-urethral fistula, would you deliberately exclude the prostate/prostatic urethra from the target volume?   

If you would include it, what would you anticipate in regards to the impact on this fistula?



Answer from: Radiation Oncologist at Academic Institution